TIE2-expressing monocytes/macrophages regulate revascularization of the ischemic limb

EMBO Molecular Medicine

Volumn 5, Issue 6, 2013, Pages 858-869

  Patel, Ashish S ^a   Smith, Alberto ^a   Nucera, Silvia ^b,c   Biziato, Daniela ^b,c,d   Saha, Prakash ^a   Attia, Rizwan Q ^a   Humphries, Julia ^a   Mattock, Katherine ^a   Grover, Steven P ^a   Lyons, Oliver T ^a   Guidotti, Luca G ^b   Siow, Richard ^e   Ivetic, Aleksandar ^e   Egginton, Stuart ^f   Waltham, Matthew ^a   Naldini, Luigi ^b,c   De Palma, Michele ^b,d   Modarai, Bijan ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d EPFL   (Switzerland)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Angiogenesis; Limb ischemia; Macrophages; Monocytes; TIE2

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; FEMALE; FLOW CYTOMETRY; GANGRENE; GASTROCNEMIUS MUSCLE; GENE SILENCING; HINDLIMB; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN VITRO STUDY; ISCHEMIC HEART DISEASE; LIMB AMPUTATION; LIMB ISCHEMIA; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; ANIMALS; FEMALE; HUMANS; ISCHEMIA; MACROPHAGES; MALE; MICE; MICRORNAS; MIDDLE AGED; MONOCYTES; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, TIE-2; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878739686     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201302752     Document Type: Article

References (34)

1. Albers M, Fratezi AC, De Luccia N (1992) Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. J Vasc Surg 16: 54-59
2. Amendola M, Passerini L, Pucci F, Gentner B, Bacchetta R, Naldini L (2009) Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform. Mol Ther 17: 1039-1052
3. Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, Van BE (2011) Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 377: 1929-1937
4. Berger JS, Hiatt WR (2012) Medical therapy in peripheral artery disease. Circulation 126: 491-500
5. Brandao D, Costa C, Canedo A, Vaz G, Pignatelli D (2011) Endogenous vascular endothelial growth factor and angiopoietin-2 expression in critical limb ischemia. Int Angiol 30: 25-34
6. Capobianco A, Monno A, Cottone L, Venneri MA, Biziato D, Di Puppo F, Ferrari S, De Palma M, Manfredi AA, Rovere-Querini P (2011) Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. Am J Pathol 179: 2651-2659
7. Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, Urbich C, Biswas SK, Murdoch C, Plate KH, Reiss Y, et al (2010) Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res 70: 5270-5280
8. De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE (2007) Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 28: 519-524
9. De Palma M, Venneri MA, Galli R, Sergi SL, Politi LS, Sampaolesi M, Naldini L (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226
10. Fadini GP, Agostini C, Avogaro A (2010) Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis 209: 10-17
11. Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S, Peri F, Wilson SW, Ruhrberg C (2010) Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116: 829-840
12. Findley CM, Mitchell RG, Duscha BD, Annex BH, Kontos CD (2008) Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol 52: 387-393
13. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K (2010) Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661
14. Hamm A, Veschini L, Takeda Y, Costa S, Delamarre E, Squadrito ML, Henze A.-T, Wenes M, Serneels J, Pucci F et al (2013) PHD2 regulates arteriogenic macrophages through TIE2 signalling. EMBO Mol Med, DOI: 10.1002/emmm.201302695
15. He H, Xu J, Warren CM, Duan D, Li X, Wu L, Iruela-Arispe ML, (2012) Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages. Blood 120: 3152-3162
16. Jeong JO, Kim MO, Kim H, Lee MY, Kim SW, Ii M, Lee JU, Lee J, Choi YJ, Cho HJ, et al (2009) Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 119: 699-708
17. Kim MS, Lee CS, Hur J, Cho HJ, Jun SI, Kim TY, Lee SW, Suh JW, Park KW, Lee HY, et al (2009) Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway. Circulation 120: 2240-2250
18. Klimchenko O, Di SA, Geoerger B, Hamidi S, Opolon P, Robert T, Routhier M, El-Benna J, Delezoide AL, Boukour S, et al (2011) Monocytic cells derived from human embryonic stem cells and fetal liver share common differentiation pathways and homeostatic functions. Blood 117: 3065-3075
19. Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ, et al (2002) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359: 2053-2058
20. Losordo DW, Dimmeler S (2004) Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 109: 2692-2697
21. Marston WA, Davies SW, Armstrong B, Farber MA, Mendes RC, Fulton JJ, Keagy BA (2006) Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 44: 108-114
22. Matsubara T, Kanto T, Kuroda S, Yoshio S, Higashitani K, Kakita N, Miyazaki M, Sakakibara M, Hiramatsu N, Kasahara A, et al (2013) TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlated with angiogenesis. Hepatology 57: 1416-1425
23. Mazzieri R, Pucci F, Moi D, Zonari E, Ranghetti A, Berti A, Politi LS, Gentner B, Brown JL, Naldini L, et al (2011) Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19: 512-526
24. Moazzami K, Majdzadeh R, Nedjat S (2011) Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia. Cochrane Database Syst Rev 12: CD008347
25. Modarai B, Burnand KG, Sawyer B, Smith A (2005) Endothelial progenitor cells are recruited into resolving venous thrombi. Circulation 111: 2645-2653
26. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 (Suppl S), S5-67
27. Pucci F, Venneri MA, Biziato D, Nonis A, Moi D, Sica A, Di Serio C, Naldini L, De Palma M (2009) A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114: 901-914
28. Rajagopalan S, Mohler ER, III, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, et al (2003) Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108: 1933-1938
29. Reiss Y, Droste J, Heil M, Tribulova S, Schmidt MH, Schaper W, Dumont DJ, Plate KH (2007) Angiopoietin-2 impairs revascularization after limb ischemia. Circ Res 101: 88-96
30. Takeda Y, Costa S, Delamarre E, Roncal C, Leite de Oliveira R, Squadrito ML, Finisguerra V, Deschoemaeker S, Bruyere F, Wenes M, et al (2011) Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479: 122-126
31. Tressel SL, Kim H, Ni CW, Chang K, Velasquez-Castano JC, Taylor WR, Yoon YS, Jo H (2008) Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis. Arterioscler Thromb Vasc Biol 28: 1989-1995
32. Tuomisto TT, Rissanen TT, Vajanto I, Korkeela A, Rutanen J, Yla-Herttuala S (2004) HIF-VEGF-VEGFR-2, TNF-alpha and IGF pathways are upregulated in critical human skeletal muscle ischemia as studied with DNA array. Atherosclerosis 174: 111-120
33. Varu VN, Hogg ME, Kibbe MR (2010) Critical limb ischemia. J Vasc Surg 51: 230-241
34. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, Heine GH (2011) SuperSAGE evidence for CD14 + +CD16+ monocytes as a third monocyte subset. Blood 118: e50- e61